A spontaneous report is an unsolicited communication by a healthcare professional or consumer to a company, regulatory authority, or other organization that describes one or more adverse drug reactions in a patient who was given one or more medicinal products. These reports are typically submitted voluntarily when an unexpected or concerning event occurs during normal clinical practice.
Spontaneous reports play a crucial role in post-marketing drug safety surveillance, helping to identify potential new adverse reactions or changes in the severity or frequency of known side effects. While they have limitations, such as potential underreporting and lack of denominator data, spontaneous reports are valuable for generating safety signals and hypotheses for further investigation.
Spontaneous reports are crucial in clinical research as they provide real-world data on drug safety and efficacy beyond controlled clinical trials. They allow researchers and regulatory authorities to identify potential adverse reactions that may not have been observed during pre-market studies, contributing to ongoing safety assessments of marketed drugs.
The importance of spontaneous reports lies in their ability to detect rare or long-term side effects that may not be apparent in shorter-duration clinical trials. This information helps in updating product labels, issuing safety alerts, and guiding further research, ultimately enhancing patient safety and improving the overall understanding of a drug’s risk-benefit profile.
Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…
Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…
Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…
Copyright @ 2025 Axcellant